List of insiders holdings for Assertio Therapeutics Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Molinelli Gavin Director |
2017-03-30 21:03:21 | 29,268 5,295,271 |
5,324,539 | Form 4 |
2 | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC 10% Owner |
2013-02-14 08:06:45 | 2,475,016 0 |
2,475,016 | Form 13G |
3 | BIOVAIL LABORATORIES INC 10% Owner |
2008-09-19 11:02:36 | 2,364,987 0 |
2,364,987 | Form 13D |
4 | CALLAGHAN MICHAEL J Director |
2004-03-09 13:41:28 | 0 2,181,412 |
2,181,412 | Form 4 |
5 | HIGGINS ARTHUR J Director, President and CEO |
2020-02-12 18:41:18 | 439,564 178,000 |
617,564 | Form 4 |
6 | Schoeneck James A President and CEO |
2017-02-10 19:40:47 | 0 495,105 |
495,105 | Form 5 |
7 | STAPLE PETER D Director |
2019-11-12 16:36:48 | 207,880 13,900 |
221,780 | Form 4 |
8 | HAMILTON JOHN F VP & CFO |
2007-10-12 18:15:02 | 205,644 0 |
205,644 | Form 4 |
9 | Peisert Daniel A. SVP and CFO |
2020-02-12 18:41:39 | 158,383 0 |
158,383 | Form 4 |
10 | Wheadon David E. Director |
2019-10-01 17:15:53 | 145,038 0 |
145,038 | Form 4 |
11 | FOGARTY JAMES P Director |
2019-05-09 11:28:57 | 106,796 0 |
106,796 | Form 4 |
12 | Bukofzer Stan SVP, Chf Scitfc & Tech Officer |
2020-04-03 19:54:36 | 103,500 0 |
103,500 | Form 4/A |
13 | Pelzel Carl A President and CEO |
2011-01-14 17:11:52 | 100,000 0 |
100,000 | Form 4 |
14 | Zenoff David B Director |
2017-02-23 19:03:16 | 0 93,999 |
93,999 | Form 4 |
15 | Donenberg Phillip B. SVP and CFO |
2018-07-16 16:10:12 | 87,163 0 |
87,163 | Form 4 |
16 | DAWES KAREN A Director |
2020-05-11 20:23:47 | 84,589 0 |
84,589 | Form 4 |
17 | BERNER BRET VP & CSO |
2006-02-14 13:14:26 | 84,000 0 |
84,000 | Form 4 |
18 | Tyree James L Director |
2019-05-09 11:31:07 | 80,590 0 |
80,590 | Form 4 |
19 | Moretti August J Chief Financial Officer & SVP |
2018-04-03 20:35:22 | 74,447 0 |
74,447 | Form 4 |
20 | MCKEE WILLIAM Director |
2019-05-09 18:26:24 | 67,846 0 |
67,846 | Form 4 |
21 | LAVIGNE LOUIS J JR Director |
2019-05-09 11:29:36 | 58,296 0 |
58,296 | Form 4 |
22 | Mason Heather L Director |
2020-02-19 17:00:01 | 43,182 0 |
43,182 | Form 4 |
23 | Cameron Tammy VP, Finance |
2011-09-02 17:05:35 | 37,500 0 |
37,500 | Form 4 |
24 | Galeota James JR Director |
2020-03-31 19:32:06 | 37,475 0 |
37,475 | Form 4 |
25 | Vetticaden Santosh SVP, Chief Medical Officer *** |
2018-02-08 20:14:35 | 36,800 0 |
36,800 | Form 4 |
26 | BURRILL STEVEN Director |
2013-12-12 15:10:18 | 20,000 0 |
20,000 | Form 4 |
27 | SMITH CRAIG R Director |
2012-12-06 20:23:44 | 20,000 0 |
20,000 | Form 4 |
28 | STERN JULIAN N Director |
2012-12-06 20:21:59 | 20,000 0 |
20,000 | Form 4 |
29 | Srinivas G. Rao SVP and Chief Medical Officer |
2017-04-04 20:00:50 | 19,527 0 |
19,527 | Form 4 |
30 | Savage Robert G. Director |
2016-10-19 18:25:37 | 18,485 0 |
18,485 | Form 4 |
31 | THOMPSON W LEIGH MD PHD Director |
2003-12-22 14:14:55 | 15,000 0 |
15,000 | Form 4 |
32 | SHELL JOHN W Director |
2006-12-07 14:45:49 | 15,000 0 |
15,000 | Form 4 |
33 | FARA JOHN W Director |
2007-12-07 16:55:05 | 15,000 0 |
15,000 | Form 4 |
34 | Saks Samuel R Director |
2016-05-20 19:05:50 | 10,800 0 |
10,800 | Form 4 |
35 | SHELL JOHN N VP, Operations |
2008-01-29 19:41:52 | 10,000 0 |
10,000 | Form 4 |
36 | Sweeney Michael MD CMO and VP, R&D |
2013-12-04 16:50:56 | 9,084 0 |
9,084 | Form 4 |
37 | PROEHL GERALD T Director |
2006-03-27 14:24:36 | 5,000 0 |
5,000 | Form 4 |
38 | ANIDO VICENTE JR Director |
2016-05-13 18:41:22 | 4,403 0 |
4,403 | Form 4 |
39 | Shively Richard Scott SVP & Chief Commercial Officer |
2016-04-05 21:15:41 | 4,290 0 |
4,290 | Form 4 |
40 | Gosling Matthew M SVP, General Counsel |
2018-05-15 18:15:41 | 0 0 |
0 | Form 4 |
41 | Vargas Thadd M SVP, Business Development |
2017-06-15 16:43:36 | 0 0 |
0 | Form 4 |